190 related articles for article (PubMed ID: 32211078)
1. Preparation, characterization, and
Dong W; Su X; Xu M; Hu M; Sun Y; Zhang P
Asian J Pharm Sci; 2018 Nov; 13(6):546-554. PubMed ID: 32211078
[TBL] [Abstract][Full Text] [Related]
2. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.
Shuai S; Yue S; Huang Q; Wang W; Yang J; Lan K; Ye L
Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):413-22. PubMed ID: 25669445
[TBL] [Abstract][Full Text] [Related]
3. Amorphous solid dispersion with increased gastric solubility in tandem with oral disintegrating tablets: a successful approach to improve the bioavailability of atorvastatin.
Salmani JM; Lv H; Asghar S; Zhou J
Pharm Dev Technol; 2015 Jun; 20(4):465-72. PubMed ID: 24490758
[TBL] [Abstract][Full Text] [Related]
4. Preparation, characterization and in vitro evaluation of tablets containing microwave-assisted solid dispersions of apremilast.
Madan JR; Pawar AR; Patil RB; Awasthi R; Dua K
Polim Med; 2018; 48(1):17-24. PubMed ID: 30657654
[TBL] [Abstract][Full Text] [Related]
5. Preparation, optimisation, and in vitro-in vivo evaluation of febuxostat ternary solid dispersion.
Tang J; Bao J; Shi X; Sheng X; Su W
J Microencapsul; 2018 Aug; 35(5):454-466. PubMed ID: 30229692
[TBL] [Abstract][Full Text] [Related]
6. Formulation of Gelucire®-Based Solid Dispersions of Atorvastatin Calcium: In Vitro Dissolution and In Vivo Bioavailability Study.
Aldosari BN; Almurshedi AS; Alfagih IM; AlQuadeib BT; Altamimi MA; Imam SS; Hussain A; Alqahtani F; Elzayat E; Alshehri S
AAPS PharmSciTech; 2021 May; 22(5):161. PubMed ID: 34031791
[TBL] [Abstract][Full Text] [Related]
7. Enhanced Solubility and Bioavailability of Dolutegravir by Solid Dispersion Method: In Vitro and In Vivo Evaluation-a Potential Approach for HIV Therapy.
Chaudhary S; Nair AB; Shah J; Gorain B; Jacob S; Shah H; Patel V
AAPS PharmSciTech; 2021 Apr; 22(3):127. PubMed ID: 33835317
[TBL] [Abstract][Full Text] [Related]
8. Effect of semicrystalline polymers on self-emulsifying solid dispersions of nateglinide: in vitro and in vivo evaluation.
Swain RP; Subudhi BB
Drug Dev Ind Pharm; 2018 Jan; 44(1):56-65. PubMed ID: 28845687
[TBL] [Abstract][Full Text] [Related]
9. Development of the Binary and Ternary Atorvastatin Solid Dispersions:
Faraji E; Mohammadi M; Mahboobian MM
Biomed Res Int; 2021; 2021():6644630. PubMed ID: 34527740
[TBL] [Abstract][Full Text] [Related]
10. Spectroscopic characterization and pharmacokinetic evaluation of amorphous solid dispersions of glibenclamide for bioavailability enhancement in Wistar rats.
Mir KB; Abrol V; Singh N; Khan NA; Dar AA; Alahmadi TA; Ansari MJ
Biomed Chromatogr; 2024 May; ():e5901. PubMed ID: 38816948
[TBL] [Abstract][Full Text] [Related]
11. Preparation, characterization and tableting of cilnidipine solid dispersions.
Hu L; Song W; Niu F; Jiao K; Jia Z
Pak J Pharm Sci; 2013 May; 26(3):629-36. PubMed ID: 23625441
[TBL] [Abstract][Full Text] [Related]
12. Formulation, characterization and and evaluation of aloe-emodin-loaded solid dispersions for dissolution enhancement.
Xiuyan LI; Yuting L; Jinhui W; Zhimin DU
J Tradit Chin Med; 2024 Feb; 44(1):54-62. PubMed ID: 38213239
[TBL] [Abstract][Full Text] [Related]
13. Preparation of osthole-polymer solid dispersions by hot-melt extrusion for dissolution and bioavailability enhancement.
Yun F; Kang A; Shan J; Zhao X; Bi X; Li J; Di L
Int J Pharm; 2014 Apr; 465(1-2):436-43. PubMed ID: 24576810
[TBL] [Abstract][Full Text] [Related]
14. Atorvastatin solid dispersion for bioavailability enhancement.
Shamsuddin ; Fazil M; Ansari SH; Ali J
J Adv Pharm Technol Res; 2016; 7(1):22-6. PubMed ID: 26955607
[TBL] [Abstract][Full Text] [Related]
15. Solid dispersion adsorbate technique for improved dissolution and flow properties of lurasidone hydrochloride: characterization using 3
Mahajan A; Surti N; Koladiya P
Drug Dev Ind Pharm; 2018 Mar; 44(3):463-471. PubMed ID: 29098883
[TBL] [Abstract][Full Text] [Related]
16. Preparation and physicochemical characterizations of tanshinone IIA solid dispersion.
Zhao X; Liu X; Gan L; Zhou C; Mo J
Arch Pharm Res; 2011 Jun; 34(6):949-59. PubMed ID: 21725816
[TBL] [Abstract][Full Text] [Related]
17. Selection of the suitable polymer for supercritical fluid assisted preparation of carvedilol solid dispersions.
Djuris J; Milovanovic S; Medarevic D; Dobricic V; Dapčević A; Ibric S
Int J Pharm; 2019 Jan; 554():190-200. PubMed ID: 30414899
[TBL] [Abstract][Full Text] [Related]
18. Improved solubility, dissolution, and oral bioavailability for atorvastatin-Pluronic® solid dispersions.
Shaker MA; Elbadawy HM; Shaker MA
Int J Pharm; 2020 Jan; 574():118891. PubMed ID: 31786357
[TBL] [Abstract][Full Text] [Related]
19. Physicochemical characterization and dissolution study of solid dispersions of Lovastatin with polyethylene glycol 4000 and polyvinylpyrrolidone K30.
Patel RP; Patel MM
Pharm Dev Technol; 2007; 12(1):21-33. PubMed ID: 17484141
[TBL] [Abstract][Full Text] [Related]
20. Dissolution rate enhancement and physicochemical characterization of carbamazepine-poloxamer solid dispersions.
Medarević DP; Kachrimanis K; Mitrić M; Djuriš J; Djurić Z; Ibrić S
Pharm Dev Technol; 2016; 21(3):268-76. PubMed ID: 25582577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
